Molecular glue degraders: Lilly, AbbVie sign billion-dollar deals; BMS leads with three late-stage drugs

Data Compilation
#PharmaFlow

Pipeline Prospector Feb 2025: Bain buys Mitsubishi Tanabe for US$ 3.4 bn; Japan’s Ono gets FDA nod for rare joint tumor drug

Stock Recap
#PipelineProspector

Ranolazine

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

56 API Suppliers, 28 USDMF, 17 EU WC, 2 KDMF, 22 NDC API, 38 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

1 Drugs in Development

1 Drugs in Development

INTERMEDIATES

21 Intermediate Suppliers

21 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

111 FDF Dossiers, 56 FDA Orange Book, 28 Europe, 2 Canada, 3 South Africa, 22 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET, EXTENDED RELEASE;ORAL - 1GM **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, EXTENDED RELEASE;ORAL - 500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, GRANULES, EXTENDED RELEASE;ORAL - 1GM, GRANULES, EXTENDED RELEASE;ORAL - 500MG

RELATED EXCIPIENT COMPANIES

2 Evonik, 1 SPI Pharma, 4 DKSH, 2 Faran Shimi Pharmaceutical, 3 Gangwal Healthcare, 4 Nanjing Well Pharmaceutical, 1 ACG Worldwide, 2 Actylis, 1 Aeon Procare, 1 Alcedo Pharmachem, 3 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 6 BASF, 1 Clariant, 13 Corel Pharma Chem, 4 DFE Pharma, 10 Gangwal Chemicals, 11 Ideal Cures Pvt Ltd, 31 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 10 Microlex e.U, 1 Nanjing Bold Chemical, 2 Novo Excipients, 1 Pharmatrans-Sanaq, 2 Pluviaendo, 2 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 9 Roquette, 12 Seppic, 3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 10 Sigachi Industries, 2 The Dow Chemical Company, 1 Valens Pharmachem, 2 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

64 Coating Systems & Additives, 41 Fillers, Diluents & Binders, 31 Controlled & Modified Release, 15 Thickeners and Stabilizers, 14 Solubilizers, 13 Direct Compression, 13 Film Formers & Plasticizers, 12 Lubricants & Glidants, 10 Granulation, 9 Parenteral, 8 Co-Processed Excipients, 7 Topical, 6 Taste Masking, 6 Rheology Modifiers, 6 Disintegrants & Superdisintegrants, 5 API Stability Enhancers, 5 Emulsifying Agents, 5 Empty Capsules, 4 Vegetarian Capsules, 4 Coloring Agents, 3 Surfactant & Foaming Agents, 3 Chewable & Orodispersible Aids

DIGITAL CONTENT

26 News #PharmaBuzz

26 News #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 25 Regulatory FDF Prices, 8 Annual Reports

MARKET PLACE

17 APIs, 2 FDF Dossiers

PATENTS & EXCLUSIVITIES

4 US Patents

4 US Patents

REF. STANDARDS & IMPURITIES

4 USP, 10 Others

ANALYTICAL

2 BioAnalytical Methods

2 BioAnalytical Methods

$ Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Registrant Name	Registration No.	Compound	Registration Date	Manufacturer	Manufacturer's Country	Manufacturer's Address
28/03/2025	Zhejiang Huahai Pharmaceutical	China	Menarini Korea Co., Ltd.	11-2-ND	Ranolazine	2020-03-13	Zhejiang Huahai Pharmaceutical Co., Ltd. Ltd	China	Chuannan, Duqiao, Linhai, Zhejiang, 317016, China
28/03/2025			Aging Life Science Co., Ltd.	434-66-ND	Ranolazine	2024-10-07	Aarti Pharmalabs limited(Unit-IV)	India	Plot No: E–50, 50/1 & 59/1, MIDC, Tarapur, Taluka & District: Palghar, 401 506, Maharashtra State, India

Ranolazine

Ranolazine

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

56 API Suppliers

28 USDMF

17 EU WC

2 KDMF

22 NDC API

38 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

1 Drugs in Development

INTERMEDIATES

21 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

111 FDF Dossiers

56 FDA Orange Book

28 Europe

2 Canada

3 South Africa

22 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET, EXTENDED RELEASE;ORAL - 1GM **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET, EXTENDED RELEASE;ORAL - 500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

GRANULES, EXTENDED RELEASE;ORAL - 1GM

GRANULES, EXTENDED RELEASE;ORAL - 500MG

RELATED EXCIPIENT COMPANIES

2 Evonik

1 SPI Pharma

4 DKSH

2 Faran Shimi Pharmaceutical

3 Gangwal Healthcare

4 Nanjing Well Pharmaceutical

1 ACG Worldwide

2 Actylis

1 Aeon Procare

1 Alcedo Pharmachem

3 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

6 BASF

1 Clariant

13 Corel Pharma Chem

4 DFE Pharma

10 Gangwal Chemicals

11 Ideal Cures Pvt Ltd

31 Kerry

3 Kima Chemical

6 Lonza Capsugel

10 Microlex e.U

1 Nanjing Bold Chemical

2 Novo Excipients

1 Pharmatrans-Sanaq

2 Pluviaendo

2 Prachin Chemical

1 Qianhao Chemical (Hebei) Co., Ltd

1 Qualicaps

9 Roquette

12 Seppic

3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

10 Sigachi Industries

2 The Dow Chemical Company

1 Valens Pharmachem

2 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

64 Coating Systems & Additives

41 Fillers, Diluents & Binders

31 Controlled & Modified Release

15 Thickeners and Stabilizers

14 Solubilizers

13 Direct Compression

13 Film Formers & Plasticizers

12 Lubricants & Glidants

10 Granulation

9 Parenteral

8 Co-Processed Excipients

7 Topical

6 Taste Masking

TABLET, EXTENDED RELEASE;ORAL - 1GM Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET, EXTENDED RELEASE;ORAL - 500MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons